Marie Bosslett, Assistant Editor

George Martin, MD, reveals cutting-edge treatments for vitiligo, psoriasis, and psoriatic arthritis at Maui Derm NP+PA Fall 2025, enhancing patient care strategies.

Matthew Bruno, PA-C, explores the transformative impact of AI at Maui Derm NP+PA Fall, emphasizing its benefits, ethical concerns, and the need for clinician engagement.

Discover expert insights on treating uncommon conditions like lichen planus, CSU, and polymorphous light eruption from Maui Derm NP+PA Fall 2025.

Explore common dermatological nail disorders and innovative surgical techniques presented by Phoebe Rich, MD, at Maui Derm NP+PA Fall 2025.

At Maui Derm NP+PA Fall 2025, Ted Rosen, MD, and Vikash Oza, MD, discuss emerging infectious diseases in dermatology, highlighting new treatments and diagnostic challenges for clinicians.

Catch up on coverage from the second day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.

Discover expert insights on cutaneous oncology from George Martin, MD, focusing on innovative treatments for skin cancers at Maui Derm NP+PA Fall.

Discover key insights from the Maui Derm NP+PA Fall 2025 Conference on advances in dermatology, including new treatments and research findings.

Discover groundbreaking dermatologic therapies and new drug approvals presented at Maui Derm NP+PA Fall, featuring insights from experts George Martin, MD, and Ted Rosen, MD.

Berdazimer shows promise for treating MC in pediatric patients, even in those with a history of atopic dermatitis, according to a poster at Maui Derm NP+PA Fall.

Catch up on coverage from the first day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.

Elena Hawryluk, MD, PhD, highlights innovative pediatric dermatology at Maui Derm NP+PA Fall, emphasizing education and advancements in tumor genetics.

Preview the Maui Derm NP+PA Fall 2025 Conference with program director George Martin, MD, featuring cutting-edge education and expert insights in Nashville.

Preview Maui Derm NP+PA Fall 2025 Conference's 4 days of cutting-edge dermatology insights, networking, and expert-led sessions in Nashville.

Nicole Harter, MD, explores ruxolitinib 1.5% cream for pediatric atopic dermatitis, offering a novel, effective treatment option for children aged 2 to 11.

Denifanstat shows promising results in treating moderate to severe acne vulgaris, achieving significant efficacy and safety at the EADV Congress 2025.

LEO Pharma unveils promising phase 2b trial results for temtokibart, showcasing significant improvements in atopic dermatitis at EADV Congress 2025.

A new study at EADV 2025 links atopic dermatitis to increased suicidal ideation, highlighting the condition's severe psychological impact.

Sanofi's brivekimig shows promising phase 2a results for hidradenitis suppurativa (HS), offering hope for effective treatment options at EADV Congress 2025.

Join Dermatology Times at the EADV Congress 2025 for expert insights and live updates from Paris, France.

Nayan Patel, PharmD, reveals how innovative glutathione delivery transforms skin care, combats oxidative stress, and empowers skin health for lasting results.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of September.

New guidelines redefine short-term corticosteroid use in patients with AD, urging safer treatment transitions to advanced therapies for better outcomes.

Experts discuss innovative topical therapies for pediatric AD, emphasizing individualized treatment and the importance of managing itch and sleep quality.

Discover how Auro GSH by Nayan Patel, PharmD, revolutionizes glutathione delivery in skin care, targeting oxidative stress for healthier skin.

Thazin Aung, PhD, discusses AI's role in standardizing immune cell evaluation in melanoma, enhancing diagnostic consistency and clinical decision-making.

Krystal Biotech enhances B-VEC's label, empowering DEB patients with at-home treatment options and improving quality of life through innovative gene therapy.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

In case you missed it, this week we had news about the long-term safety of Amgen’s rocatinlimab for AD, the shared genetic backgrounds of cardiovascular diseases and psoriasis, the availability of LEO Pharma's delgocitinib cream, and more.

Explore the complex genetic links between psoriasis and cardiovascular diseases, highlighting the IL-23 and IL-17 pathways' role in health risks.